Akari Therapeutics to Present at Cowen and Company 36th Annual Health Care Conference
Mar 01, 2016 12:15 pm UTC| Business
NEW YORK and LONDON, March 01, 2016 -- Akari Therapeutics (NASDAQ:AKTX), an emerging growth, development-stage biopharmaceutical company, announced today that Gur Roshwalb, M.D., Chief Executive Officer, will present...
Mar 01, 2016 12:10 pm UTC| Business
New York, March 01, 2016 -- Intrommune Therapeutics, a specialty biopharmaceutical company developing a patient-friendly platform for the treatment of food allergies, announced today that the U.S Patent and Trademark...
Evogene Reports Fourth Quarter and Full Year 2015 Financial Results
Mar 01, 2016 12:07 pm UTC| Business
REHOVOT, Israel, March 01, 2016 -- Evogene Ltd. (NYSE:EVGN) (TASE:EVGN), a leading company for the improvement of crop productivity and economics for food, feed and fuel, announced today its financial results for the...
NXP’s MIFARE® DESFire® EV2 Fast Tracks Multi-Application Smart Cards
Mar 01, 2016 12:06 pm UTC| Business
KARLSRUHE, Germany, March 01, 2016 -- NXP Semiconductors N.V. (NASDAQ:NXPI) today, announced the launch of a new contactless development platform specifically designed to champion new and emerging business models for...
Agios to Present at the Cowen and Company 36th Annual Health Care Conference on Tuesday, March 8
Mar 01, 2016 12:01 pm UTC| Business
CAMBRIDGE, Mass., March 01, 2016 -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today announced the company is scheduled to present at the...
Oxford Immunotec Reports Fourth Quarter and Full Year 2015 Financial Results
Mar 01, 2016 12:00 pm UTC| Business
Fourth quarter revenue of$16.8 millionincreased 42% on a constant currency basis compared to prior year period2015 revenue of $62.8 million increased 33% on a constant currency basis compared to prior yearT-SPOT®.PRT assay...
Mar 01, 2016 12:00 pm UTC| Business
LEIDEN, the Netherlands, March 01, 2016 -- ProQR Therapeutics N.V.(Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe orphan diseases...